CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Bullock James Director | Grant or award | +7,576 | 76,223 | ||
| 2026-05-18 | BEVEVINO DANIEL J Director | Grant or award | +7,576 | 157,637 | ||
| 2026-05-18 | ACKERMAN THOMAS F Director | Grant or award | +7,576 | 157,472 | ||
| 2026-05-14 | Borgstrom Marna P Director | Grant or award | +7,850 | 56,938 | ||
| 2026-03-04 | Holloway Jean F SVP, General Counsel | Sale | −8,962 | $38.00 | $341K | 185,095 |
| 2026-03-03 | Horton Amy VP, Chief Accounting Officer | Sale | −901 | $37.78 | $34K | 139,088 |
| 2026-03-03 | Holloway Jean F SVP, General Counsel | Sale | −3,843 | $37.78 | $145K | 194,057 |
| 2026-03-03 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −2,149 | $37.78 | $81K | 60,097 |
| 2026-03-03 | Davis John E Chief Commercial Officer | Sale | −4,573 | $37.78 | $173K | 230,794 |
| 2026-03-03 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | −6,316 | $37.78 | $239K | 210,827 |
| 2026-03-03 | Mackin James P President & CEO | Sale | −17,887 | $37.78 | $676K | 947,275 |
| 2026-03-02 | Horton Amy VP, Chief Accounting Officer | Grant or award | +7,475 | 139,989 | ||
| 2026-03-02 | Holloway Jean F SVP, General Counsel | Grant or award | +27,795 | 197,900 | ||
| 2026-03-02 | Stanton Marshall S. SVP, Clinical & MD Affair | Grant or award | +21,838 | 62,246 | ||
| 2026-03-02 | Davis John E Chief Commercial Officer | Grant or award | +28,845 | 235,367 | ||
| 2026-03-02 | Berry Lance A EVP, COO, CFO & Treasurer | Grant or award | +40,874 | 217,143 | ||
| 2026-03-02 | Mackin James P President & CEO | Grant or award | +116,948 | 965,162 | ||
| 2026-03-02 | Horton Amy VP, Chief Accounting Officer | Sale | −641 | $38.02 | $24K | 132,514 |
| 2026-03-02 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −1,513 | $38.02 | $58K | 40,408 |
| 2026-03-02 | Mackin James P President & CEO | Sale | −14,911 | $38.02 | $567K | 848,214 |
Page 2 of 11 · 201 trades